NCT03304145

Brief Summary

The goal of this project is to evaluate the effectiveness of shared-decision-making (SDM) to manage chronic and breakthrough pain in patients with cancer. Providers will receive evidence-based education on shared decision-making strategies and comprehensive pain management at study start up. In addition, the information will be available on the Carevive platform for reference at the point of care. This multisite study will enroll 105 patients from three cancer institutions. This project will explore the SDM model using a touchscreen-based expanded pain assessment (EPA) to evaluate the impact of the shared-decision-making model on pain management, and explore its relationship to pain management care planning. Patients will use the Carevive Systems software in the clinic to answer questions regarding decision making preferences and complete a comprehensive assessment of their pain status. Treatment recommendations and a care plan will be provided to the patient at the time of the visit. At each clinic visit over 4 months, the patient will again complete the pain assessment and receive appropriate treatment recommendations and a revised care plan.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
Completed

Started Oct 2017

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2017

Completed
13 days until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 6, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2018

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 24, 2020

Completed
Last Updated

February 25, 2020

Status Verified

February 1, 2020

Enrollment Period

11 months

First QC Date

September 18, 2017

Last Update Submit

February 24, 2020

Conditions

Keywords

Treatment Care Planning

Outcome Measures

Primary Outcomes (1)

  • Effect of pain care plan on pain outcomes

    Pain intensity over time will be measured by the Sum of Pain Intensity Differences (SPID).

    Year 1

Secondary Outcomes (2)

  • Contribution of shared-decision-making on pain outcomes will be evaluated using the PainCQ© surveys

    Year 1

  • Feasibility of the proposed shared decision-making model to effectively manage chronic pain experienced by patients with cancer

    Year 1

Interventions

The Carevive Care Planning System (CPS) was developed to overcome challenges by providing an efficient, clinically integrated solution for both psychosocial and physical symptom distress screening and management through the delivery of personalized and evidence-based care plans at the point of care. The Carevive CPS simultaneously collects and aggregates discrete data for quality reporting and improvement.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All participants must be 18 years of age or older.
  • Patient participants must have a diagnosis of cancer
  • Patients must have screened positive for pain per a previous clinical assessment
  • All participants must be able to understand English.

You may not qualify if:

  • Any patient who cannot understand written or spoken English.
  • Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Billings Clinic

Billings, Montana, 59101, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2017

First Posted

October 6, 2017

Study Start

October 1, 2017

Primary Completion

August 31, 2018

Study Completion

February 24, 2020

Last Updated

February 25, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations